In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Guidelines in Daily Practice I: Potassium binders
Session

Event : Heart Failure 2019

Topic : Cardiovascular Pharmacotherapy

  • Session type : Guidelines in Practice
  • Date : 25 May 2019
  • Time : 11:00 - 12:00

5 presentations in this session

A patient on RAAS inhibitors with hyperkalemia.

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice I: Potassium binders
  • Speaker : EA Jankowska (Wroclaw,PL)

What do the guidelines say?

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice I: Potassium binders
  • Speaker : S Anker (Berlin,DE)

How to implement the guidelines?

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice I: Potassium binders
  • Speaker : M Lainscak (Murska Sobota,SI)

Panel discussion.

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice I: Potassium binders

Conclusion and take home message.

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice I: Potassium binders

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are